Ledger.Open graph →
SEC Form D · Amendment · filed February 13, 2020

ENB Therapeutics, Inc

Offering
$9.1M
Sold
$8.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Sumayah Jamal · New York, NYExec · DirectorAlbert Sokol · New York, NYExecFumitaka Mori · NEW YORK, NYDirectorBarbara Schilberg · New York, NYDirectorStephen Buchanan · Charlotte, NCExecJoseph Strycharz · Charlotte, NCExec · DirectorBridget M. Cole · WALTHAM, MADirectorWilliam Hayes · Charlotte, NCDirectorJames Howes · Sydney NSW, Channel IslandsDirectorAndrew White · SANTA FE SPRINGS, CADirectorTejroop S. Sehmi · SANTA FE SPRINGS, CAExec · DirectorNavjot S. Sehmi · SANTA FE SPRINGS, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗